Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence.
Bacchiani M, Salamone V, Massaro E, Sandulli A, Mariottini R, Cadenar A, Di Maida F, Pradere B, Mertens LS, Longoni M, Krajewski W, Del Giudice F, D'Andrea D, Laukhtina E, Shariat SF, Minervini A, Moschini M, Mari A, On Behalf Of European Association Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group. Bacchiani M, et al. Among authors: moschini m. Cancers (Basel). 2023 May 28;15(11):2951. doi: 10.3390/cancers15112951. Cancers (Basel). 2023. PMID: 37296913 Free PMC article. Review.
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups.
Suardi N, Dell'Oglio P, Gallina A, Gandaglia G, Buffi N, Moschini M, Fossati N, Lughezzani G, Karakiewicz PI, Freschi M, Lucianò R, Shariat SF, Guazzoni G, Gaboardi F, Montorsi F, Briganti A. Suardi N, et al. Among authors: moschini m. Urol Oncol. 2016 Feb;34(2):57.e1-7. doi: 10.1016/j.urolonc.2015.08.019. Epub 2015 Oct 1. Urol Oncol. 2016. PMID: 26427694
Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis.
Moschini M, Karnes RJ, Gandaglia G, Luzzago S, Dell'Oglio P, Rossi MS, di Trapani E, La Croce G, Damiano R, Salonia A, Shariat SF, Montorsi F, Briganti A, Gallina A, Colombo R. Moschini M, et al. Urology. 2016 Feb;88:97-103. doi: 10.1016/j.urology.2015.12.005. Epub 2015 Dec 9. Urology. 2016. PMID: 26683751
Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.
Moschini M, Bianchi M, Rossi MS, Dell׳Oglio P, Gandaglia G, Fossati N, Mattei A, Damiano R, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A. Moschini M, et al. Urol Oncol. 2016 Jun;34(6):256.e7-256.e13. doi: 10.1016/j.urolonc.2015.12.016. Epub 2016 Feb 2. Urol Oncol. 2016. PMID: 26850780
Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Moschini M, Karnes RJ, Sharma V, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Capogrosso P, Shariat SF, Damiano R, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R. Moschini M, et al. Eur J Surg Oncol. 2016 May;42(5):735-43. doi: 10.1016/j.ejso.2016.02.011. Epub 2016 Feb 18. Eur J Surg Oncol. 2016. PMID: 26927300
541 results